Pluristem Ltd.

Nirit Drori-Carmi

Moran Meiron

Amir Toren

Rachel Ofir

Zami Aberman

Harel Kasuto

Racheli Ofir

Barak Zohar

A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprises culturing the adherent cells from the placenta or adipose tissue under 3 dimensional (3D) culturing conditions which allow cell expansion, the conditions comprising perfusion.

Perfusion bioreactor for culturing CD200&#x2014;placenta adherent cells

A method of treating ischemia in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the ischemia in the subject. A method of treating a medical condition requiring connective tissue regeneration and/or repair is also disclosed.

Adherent cells from adipose or placenta tissues and use thereof in therapy

A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta or adipose tissue under 2 dimensional (2D) culturing conditions which allow cell expansion, the conditions comprising continuous passaging of the cells for at least 4 passages.

Adherent cells from placenta tissue and use thereof in therapy

A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta or adipose tissue under 3 dimensional (3D) culturing conditions which allow cell expansion, the conditions comprising perfusion.

Growing community of inventors

Doar-Na Hof HaCarmel, Israel

Nirit Drori-Carmi